SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-05-088711
Filing Date
2005-04-28
Accepted
2005-04-28 16:57:19
Documents
5
Period of Report
2005-06-17
Effectiveness Date
2005-04-28

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT ddef14a.htm DEF 14A 603660
2 GRAPHIC g98948g88d11.jpg GRAPHIC 10359
3 GRAPHIC g98948g94c27.jpg GRAPHIC 62681
4 GRAPHIC g98948g97z57.jpg GRAPHIC 7065
5 GRAPHIC g98948g98o61.jpg GRAPHIC 13135
  Complete submission text file 0001193125-05-088711.txt   734162
Mailing Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119
Business Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062707100
CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-12465 | Film No.: 05781374
SIC: 2834 Pharmaceutical Preparations